AI capex boom fuels demand narrative, but CoreWeave still needs to deliver on ramp

What happened

Hyperscaler AI capex surged to $700–725 billion in 2026, reinforcing supply constraints and sustaining strong pricing for GPU infrastructure providers like CoreWeave. CoreWeave's Q1 revenue is expected near $1.96 billion, but the market reaction will hinge on guidance, backlog conversion, and management's tone on demand. The DeepValue report maintains that CRWV's valuation is expectation-heavy, with multiples compressing only if the $60.7B backlog converts efficiently and ARR ramps as planned. Margin expansion remains uncertain until 2028 due to heavy upfront capex and financing costs, and the mid-2027 DSCR covenant test looms as a key risk. While the AI boom headlines support the demand narrative, the equity remains path-dependent on 2026 commissioning throughput and covenant compliance, warranting a wait-and-see approach.

Implication

The $700B AI capex boom reinforces long-term demand, but execution on commissioning and margin expansion is essential. Investors should wait for evidence of ramp before adding, as the stock remains vulnerable to covenant tests and dilution.

Thesis delta

The $700B AI capex surge reinforces the long-term demand thesis but does not change the near-term execution and financing risks. The stock still needs to prove it can convert backlog into revenue and operating income without covenant strain. The call remains WAIT with attractive entry at $95.